A single amino acid change in a neuronal ion channel called KCNQ2 blocks ion flow, prevents protein localization on axons, and results in severe epilepsy and slowed neurological development.

FHL-101 is under clinical development by Forest Hills Partners Hong Kong and currently in Phase I for Unspecified Neurologic Disorders.

Etiologies vary by age with metabolic and infectious diseases ... in children than adults but are dependent upon the degree of encephalopathy and diagnosis.

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three-year highs in response to breakthrough innovations and ...

Advances in science and technology have allowed researchers to gain a better understanding of the pathophysiology leading to long-term neurologic damage in newborns. Intrapartum events are now ...

Government initiatives and healthcare reforms aimed at addressing metabolic disorders have played a pivotal role in shaping the market landscape. The market is anticipated to continue its growth ...

Causes of cirrhosis include metabolic dysfunction-associated steatotic liver disease (MASLD), hepatitis, long-term alcohol use, and primary sclerosing cholangitis. According to the National ...